Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes
We hypothesize that our proposed technology can enable improved discrimination between benign versus malignant lung nodules than has been achievable by clinical and radiomic analysis previously. Additionally, we believe that the machine learning classifier developed as part of this project will have direct clinical utility for lung cancer screening and could serve as a decision support tool.
Training the machine learning classifier: The most discriminative radiomic features will be determined via cross-validation and Linear/Quadratic Discriminant Analysis (L/QDA) on the learning set. To mitigate selection and classifier training bias, a three-fold (one fold held-out for testing), patient-stratified, cross-validation scheme will be used and both classification selection strategies will be repeated 1000 times. The sensitivity and the specificity of each feature will be evaluated by Receiver operating characteristic (ROC) curve and AUC analysis.
1) Optimize machine learning classifiers with radiomic features of nodular morphology on Chest radiographs to distinguish benign from malignant nodules.
2) Validate the machine learning classifier developed in Aim 1 to distinguish benign from malignant nodules on an independent test set
3) Our research lab has extensive experience in constructing AI algorithms for Radiology images (CxR, CT, MRI) as well as Histopathology images (digitized H&E Whole slide images). We would like access to the corresponding pathology images to construct and validate integrated Radiology+Pathology AI algorithms.
Dr. Vamsidhar Velcheti, MD - New York University Perlmutter Cancer Center
Dr. Robert Gilkeson, MD - University Hospitals, Cleveland
Dr. Amit Gupta, MD, University Hospitals, Cleveland
Dr. Frank Jacono, MD - Louis Stokes Cleveland VA Medical Center, Cleveland
Dr. Nathan Pennell, MD- Taussig Cancer Center, Cleveland Clinic